Home › Funds › PSP Research LLC › DNTH
PSP Research LLC position in DNTH
DIANTHUS THERAPEUTICS INC · Health Care
PSP Research LLC reported holding 2,500 shares of DNTH (DIANTHUS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$220K, representing 0.15% of its reported portfolio and ranking #32 among its reported holdings. PSP Research LLC has disclosed DNTH holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How PSP Research LLC's DNTH position evolved
PSP Research LLC first disclosed a stake in DNTH in Q4 2025 at 12,725 shares (US$524K). Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,500 shares valued at US$220K. Notable position changes include a 61% trim in Q1 2026 (shares rose 16% over the following quarter), a 50% trim in Q2 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 12.72K | $524.40K | New |
| Q1 2026 | 5.00K | $419.60K | Reduce |
| Q2 2026 | 2.50K | $243.70K | Reduce |
| Q3 2026 | 2.50K | $220.12K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DNTH and 13F data
DNTH (DIANTHUS THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DNTH
- Fairmount Funds Management LLC 2.54M sh · $247.33M · Q2 2026
- Avidity Partners Management LP 2.10M sh · $205.12M · Q2 2026
- Octagon Capital Advisors LP 1.84M sh · $179.53M · Q2 2026
- TCG Crossover Management, LLC 1.68M sh · $163.44M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 1.30M sh · $126.97M · Q2 2026
- Venrock Adviser, LLC 1.18M sh · $115.03M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.13M sh · $109.70M · Q2 2026
- BAKER BROS. ADVISORS LP 852.16K sh · $83.07M · Q2 2026
- Logos Global Management LP 800.00K sh · $77.98M · Q2 2026
- Cormorant Asset Management, LP 750.00K sh · $73.11M · Q2 2026
- BRAIDWELL LP 594.56K sh · $57.96M · Q2 2026
- MPM BioImpact LLC 420.00K sh · $40.94M · Q2 2026
More on PSP Research LLC
FAQ
How long has PSP Research LLC held DNTH?
PSP Research LLC has disclosed DNTH holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is PSP Research LLC's current position in DNTH?
As of Q3 2026, PSP Research LLC holds 2.50K shares of DNTH (DIANTHUS THERAPEUTICS INC), valued at $220.12K, representing 0.15% of its reported portfolio and ranking #32.
Has PSP Research LLC been buying or selling DNTH?
In the latest 13F filing (Q3 2026), PSP Research LLC held unchanged its position in DNTH.
Which other funds hold DNTH?
Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.